FDA's 'Radical' Abortion Pill Stance Fails, 5th Circ. Told
By Hannah Albarazi · May 9, 2023, 10:15 PM EDT
Anti-abortion groups challenging the U.S. Food and Drug Administration's approval of mifepristone in 2000 slammed the agency's allegedly "decades-long pattern of delay and obfuscation" and urged the Fifth Circuit to uphold...
To view the full article, register now.